Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP204085.RArBG1Ob6e2JmzdSjy1sEvk0Q4qJ1nP6z_phGq1ONG-Qg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP204085.RArBG1Ob6e2JmzdSjy1sEvk0Q4qJ1nP6z_phGq1ONG-Qg130_assertion type Assertion NP204085.RArBG1Ob6e2JmzdSjy1sEvk0Q4qJ1nP6z_phGq1ONG-Qg130_head.
- NP204085.RArBG1Ob6e2JmzdSjy1sEvk0Q4qJ1nP6z_phGq1ONG-Qg130_assertion description "[Higher rate of NY-ESO-1 expression was noted in breast cancer with high histological grade and negative hormone receptor status ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP204085.RArBG1Ob6e2JmzdSjy1sEvk0Q4qJ1nP6z_phGq1ONG-Qg130_provenance.
- NP204085.RArBG1Ob6e2JmzdSjy1sEvk0Q4qJ1nP6z_phGq1ONG-Qg130_assertion evidence source_evidence_literature NP204085.RArBG1Ob6e2JmzdSjy1sEvk0Q4qJ1nP6z_phGq1ONG-Qg130_provenance.
- NP204085.RArBG1Ob6e2JmzdSjy1sEvk0Q4qJ1nP6z_phGq1ONG-Qg130_assertion SIO_000772 15026363 NP204085.RArBG1Ob6e2JmzdSjy1sEvk0Q4qJ1nP6z_phGq1ONG-Qg130_provenance.
- NP204085.RArBG1Ob6e2JmzdSjy1sEvk0Q4qJ1nP6z_phGq1ONG-Qg130_assertion wasDerivedFrom lhgdn-20090331 NP204085.RArBG1Ob6e2JmzdSjy1sEvk0Q4qJ1nP6z_phGq1ONG-Qg130_provenance.
- NP204085.RArBG1Ob6e2JmzdSjy1sEvk0Q4qJ1nP6z_phGq1ONG-Qg130_assertion wasGeneratedBy ECO_0000203 NP204085.RArBG1Ob6e2JmzdSjy1sEvk0Q4qJ1nP6z_phGq1ONG-Qg130_provenance.